Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
TWST Twist Bioscience Corp
- Stocks
- Healthcare
- NASDAQ: TWST
Price (delayed)
$30.1
Market cap
$1.8B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.25
Enterprise value
$1.69B
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of
Highlights
TWST's gross profit has surged by 53% year-on-year and by 10% since the previous quarter
TWST's revenue is up by 25% YoY and by 5% from the previous quarter
Twist Bioscience's debt has increased by 7% YoY but it has decreased by 2.4% from the previous quarter
Twist Bioscience's equity has decreased by 21% YoY and by 3.5% QoQ
TWST's quick ratio is down by 16% year-on-year and by 8% since the previous quarter
Key stats
What are the main financial stats of TWST
Market
Valuations
Earnings
Shares outstanding
59.92M
Market cap
$1.8B
Enterprise value
$1.69B
Price to earnings (P/E)
N/A
Price to book (P/B)
4.08
Price to sales (P/S)
5.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.86
Revenue
$347.68M
Gross profit
$162.37M
Operating income
-$201.17M
Net income
-$191.15M
EBIT
-$190.59M
EBITDA
-$162.41M
Free cash flow
-$65.49M
Per share
Balance sheet
Liquidity
EPS
-$3.25
EPS diluted
-$3.25
Free cash flow per share
-$1.1
Book value per share
$7.38
Revenue per share
$5.83
TBVPS
$8.31
Total assets
$595.62M
Total liabilities
$155.51M
Debt
$95.3M
Equity
$440.11M
Working capital
$263.47M
Debt to equity
0.22
Current ratio
4.51
Quick ratio
4.1
Net debt/EBITDA
0.71
Margins
Efficiency
Dividend
EBITDA margin
-46.7%
Gross margin
46.7%
Net margin
-55%
Operating margin
-57.9%
Return on assets
-31.1%
Return on equity
-41.1%
Return on invested capital
-61.8%
Return on capital employed
-36.6%
Return on sales
-54.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TWST stock price
How has the Twist Bioscience stock price performed over time
Intraday
1.96%
1 week
-7.7%
1 month
-23.8%
1 year
-37.76%
YTD
-35.23%
QTD
-23.33%
Financial performance
How have Twist Bioscience's revenue and profit performed over time
Revenue
$347.68M
Gross profit
$162.37M
Operating income
-$201.17M
Net income
-$191.15M
Gross margin
46.7%
Net margin
-55%
TWST's gross profit has surged by 53% year-on-year and by 10% since the previous quarter
TWST's revenue is up by 25% YoY and by 5% from the previous quarter
Twist Bioscience's operating margin has increased by 22% YoY and by 8% QoQ
TWST's gross margin is up by 22% year-on-year and by 4.7% since the previous quarter
Price vs fundamentals
How does TWST's price correlate with its fundamentals
Growth
What is Twist Bioscience's growth rate over time
Valuation
What is Twist Bioscience stock price valuation
P/E
N/A
P/B
4.08
P/S
5.16
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
4.86
TWST's EPS is up by 3.8% since the previous quarter and by 3.3% year-on-year
TWST's P/B is 28% below its last 4 quarters average of 5.7 and 23% below its 5-year quarterly average of 5.3
Twist Bioscience's equity has decreased by 21% YoY and by 3.5% QoQ
TWST's P/S is 74% below its 5-year quarterly average of 19.9 and 38% below its last 4 quarters average of 8.3
TWST's revenue is up by 25% YoY and by 5% from the previous quarter
Efficiency
How efficient is Twist Bioscience business performance
The return on equity has declined by 30% year-on-year and by 3% since the previous quarter
The ROA has decreased by 22% YoY
TWST's return on sales is up by 20% year-on-year and by 8% since the previous quarter
Twist Bioscience's ROIC has decreased by 17% YoY
Dividends
What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TWST.
Financial health
How did Twist Bioscience financials performed over time
The current ratio has contracted by 18% YoY and by 9% from the previous quarter
TWST's quick ratio is down by 16% year-on-year and by 8% since the previous quarter
Twist Bioscience's debt is 78% less than its equity
Twist Bioscience's debt to equity has increased by 38% YoY and by 4.8% QoQ
Twist Bioscience's equity has decreased by 21% YoY and by 3.5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.